NASDAQ:IMRA

Imara Stock Insider Trading

etoro logo Buy IMRA
*Your capital is at risk
$17.59
+0.359 (+2.08%)
At Close: Jun 23, 2026

IMARA Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 255.94K and sold 154.15K IMRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 255.94K shares
Sell 154.15K shares
52% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 02, 2024
Sell
Common Stock
S-Sale
Patel Anish
Chief Operating Officer
C-Suite Officer 11 000
Value: $165.1K
Jan 02, 2024
Buy
Employee Stock Option (right to buy)
M-Exempt
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 9 383
Value: $23.3K
Jan 02, 2024
Buy
Common Stock
M-Exempt
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 9 383
Value: $23.3K
Jan 02, 2024
Sell
Common Stock
S-Sale
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 9 383
Value: $140.8K
Jan 02, 2024
Sell
Common Stock
S-Sale
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 9 383
Value: $140.8K
Jan 02, 2024
Buy
Common Stock
M-Exempt
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 9 383
Value: $23.3K
Jan 02, 2024
Buy
Employee Stock Option (right to buy)
M-Exempt
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 9 383
Value: $23.3K
Jan 02, 2024
Sell
Common Stock
S-Sale
Patel Anish
Chief Operating Officer
C-Suite Officer 11 000
Value: $165.1K
Dec 29, 2023
Buy
Stock Option (right to buy)
M-Exempt
Lyssikatos Joseph P
Chief Scientific Officer
Officer 12 000
Value: $13.4K
Dec 29, 2023
Buy
Common Stock
M-Exempt
Lyssikatos Joseph P
Chief Scientific Officer
Officer 12 000
Value: $13.4K
Dec 29, 2023
Sell
Common Stock
S-Sale
Lyssikatos Joseph P
Chief Scientific Officer
Officer 9 151
Value: $129.3K
Dec 29, 2023
Sell
Common Stock
S-Sale
Lyssikatos Joseph P
Chief Scientific Officer
Officer 2 849
Value: $42.1K
Dec 29, 2023
Sell
Common Stock
S-Sale
Lyssikatos Joseph P
Chief Scientific Officer
Officer 2 849
Value: $42.1K
Dec 29, 2023
Sell
Common Stock
S-Sale
Lyssikatos Joseph P
Chief Scientific Officer
Officer 9 151
Value: $129.3K
Dec 29, 2023
Buy
Common Stock
M-Exempt
Lyssikatos Joseph P
Chief Scientific Officer
Officer 12 000
Value: $13.4K
Dec 29, 2023
Buy
Stock Option (right to buy)
M-Exempt
Lyssikatos Joseph P
Chief Scientific Officer
Officer 12 000
Value: $13.4K
Dec 29, 2023
Sell
Common Stock
S-Sale
Patel Anish
Chief Operating Officer
C-Suite Officer 20
Value: $300
Dec 29, 2023
Buy
Employee Stock Option (right to buy)
M-Exempt
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 20
Value: $50
Dec 29, 2023
Buy
Common Stock
M-Exempt
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 20
Value: $50
Dec 29, 2023
Sell
Common Stock
S-Sale
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 20
Value: $300
Dec 29, 2023
Sell
Common Stock
S-Sale
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 20
Value: $300
Dec 29, 2023
Buy
Common Stock
M-Exempt
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 20
Value: $50
Dec 29, 2023
Buy
Employee Stock Option (right to buy)
M-Exempt
Hohl Benjamin
Chief Financial Officer
C-Suite Officer 20
Value: $50
Dec 29, 2023
Sell
Common Stock
S-Sale
Patel Anish
Chief Operating Officer
C-Suite Officer 20
Value: $300
Dec 28, 2023
Sell
Common Stock
S-Sale
Patel Anish
Chief Operating Officer
C-Suite Officer 2 520
Value: $38.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IMARA INC
IMARA
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for th...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE